Filing Details

Accession Number:
0001127602-14-026756
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-28 19:27:00
Reporting Period:
2014-08-26
Filing Date:
2014-08-28
Accepted Time:
2014-08-28 19:27:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
97745 Thermo Fisher Scientific Inc. TMO Measuring & Controlling Devices, Nec (3829) 042209186
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216070 H Seth Hoogasian 81 Wyman Street
Waltham MA 02451
Sr. Vp, Gen. Counsel & Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-08-26 1,154 $120.71 43,338 No 4 F Direct
Common Stock Acquisiton 2014-08-27 1,812 $49.49 45,150 No 4 M Direct
Common Stock Acquisiton 2014-08-27 7,775 $54.97 52,925 No 4 M Direct
Common Stock Disposition 2014-08-27 10,577 $120.77 42,348 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-08-27 1,812 $0.00 1,812 $49.49
Common Stock Stock Option (Right to Buy) Disposition 2014-08-27 7,775 $0.00 7,775 $54.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,813 2012-03-05 2017-03-05 No 4 M Direct
8,325 2018-02-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 407 Indirect By 401(k)
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.49 to $120.90, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2012, 2013 and 2014, and the next installment becomes exercisable on March 5, 2015.
  4. The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013 and 2014, and the next installment becomes exercisable on February 23, 2015.